Team
Dual-use Expert
Lieutenant Herrera conducted research at the U.S. Army Medical Research Institute of Chemical Defense and explored problem driven neurochemical systems. Connected to DoD.
Mission
Increase U.S. military readiness by scaling non-dilutive defense capital to de-risk therapeutics relevant for warfighters and global markets
Increasing muscle mass
Decreasing warfighter training time by improving muscle mass without steroids
Chemical protection
Protection against endo - exogenous chemicals, covering drug overdose
Reduce visceral fat
Optimize health and lifespan by controlling excessive hunger
Legion Therapeutics 2026
Gene Therapy for Muscle Recovery & Growth
Ln-1 plays a key role in muscle hypertrophy, repair, and vascularization. Our gene therapy delivers Ln-1 selectively to skeletal muscle via systemic administration, activating local growth without elevating systemic hormone levels.
Bioscavenger for Fentanyl Prophylaxis
Fentanyl and its analogs are the #1 Killer of Americans aged 18-45, being 195 U.S. citizens every day. Warfighters face the risk of exposure to potent synthetic opioids during chemical warfare attacks. Ln-2 attacks this public safety threat.
Buccal Appetite Regulator
Regulating appetite not via nausea, but via the central pathway for hunger. Our Ln-3 oral mucosal peptide analog is optimized for buccal delivery, engineered from canonical amino acids for selectivity and enzymolytic resistance.
Our drug development pipeline leverages modular AI and robotics capabilities from target identification through the preclinical stage
Outcomes
Next-gen AI therapeutics development for achieving U.S. warfighter casulaty reduction and medical spin-outs
01
Next-Gen AI in Therapeutics Development
We deeply understand what it takes to stay at the forefront in the age of AI, using modular and scalable systems from target discovery up until the pre IND stage.
02
Armed with insights and experience in high-throughput robotics medicated research we collaborate with the US army to bring complex concepts to life, blending functionality with ease of use - serving our in-house feedback models.
03
Dual-use: Civilian & Casualty Reduction
Our technologies are uniquely positioned to deliver dual-use therapeutics for US warfighters, recruits and civilians.
04
Medical Spin-off Creation
The culmination of our bioinformatical and wet-lab efforts allow us to create novel technologies that have the potential for individual investment and growth.